These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 29019269)

  • 1. The burden of severe hypoglycemia in type 1 diabetes.
    Liu J; Wang R; Ganz ML; Paprocki Y; Schneider D; Weatherall J
    Curr Med Res Opin; 2018 Jan; 34(1):171-177. PubMed ID: 29019269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The burden of severe hypoglycemia in type 2 diabetes.
    Liu J; Wang R; Ganz ML; Paprocki Y; Schneider D; Weatherall J
    Curr Med Res Opin; 2018 Jan; 34(1):179-186. PubMed ID: 29017368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Cumulative Multimorbidity, Glycemic Control, and Medication Use With Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Adults With Diabetes.
    McCoy RG; Lipska KJ; Van Houten HK; Shah ND
    JAMA Netw Open; 2020 Jan; 3(1):e1919099. PubMed ID: 31922562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare resource utilization and cost among patients with type 1 diabetes in the United States.
    Simeone JC; Shah S; Ganz ML; Sullivan S; Koralova A; LeGrand J; Bushman J
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1399-1410. PubMed ID: 33119443
    [No Abstract]   [Full Text] [Related]  

  • 5. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.
    Giorda CB; Rossi MC; Ozzello O; Gentile S; Aglialoro A; Chiambretti A; Baccetti F; Gentile FM; Romeo F; Lucisano G; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):209-216. PubMed ID: 28017523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization.
    Dalal MR; Kazemi M; Ye F; Xie L
    Adv Ther; 2017 Sep; 34(9):2083-2092. PubMed ID: 28779282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Impact of Treatment Duration and Persistence with Basal Insulin in Previously Insulin-Naive Users.
    Kalirai S; Duan R; Liu D; Reed BL
    J Manag Care Spec Pharm; 2017 Mar; 23(3):327-336. PubMed ID: 28230446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States.
    Bajpai S; Wong-Jacobson S; Liu D; Mitchell B; Haynes G; Syring K; Ali AK; Chinthammit C
    J Manag Care Spec Pharm; 2021 Mar; 27(3):385-391. PubMed ID: 33645242
    [No Abstract]   [Full Text] [Related]  

  • 9. Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes.
    Eby EL; Van Brunt K; Brusko C; Curtis B; Lage MJ
    Clin Interv Aging; 2015; 10():991-1001. PubMed ID: 26124652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a clinical pharmacy program on changes in hemoglobin A1c, diabetes-related hospitalizations, and diabetes-related emergency department visits for patients with diabetes in an underserved population.
    Chung N; Rascati K; Lopez D; Jokerst J; Garza A
    J Manag Care Spec Pharm; 2014 Sep; 20(9):914-9. PubMed ID: 25166290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals.
    Yue X; Wu J; Ruan Z; Wolden ML; Li L; Lin Y
    Value Health Reg Issues; 2020 May; 21():17-21. PubMed ID: 31634792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin dosing and outcomes among commercially insured patients with type 2 diabetes in the United States.
    Eby EL; Van Brunt K; Brusko C; Curtis B; Lage MJ
    Clin Ther; 2015 Oct; 37(10):2297-2308.e1. PubMed ID: 26341171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemia-related emergency department visits and hypoglycemia-related hospitalizations among new users of antidiabetes treatments.
    Moisan J; Breton MC; Villeneuve J; Grégoire JP
    Can J Diabetes; 2013 Jun; 37(3):143-9. PubMed ID: 24070836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients.
    Brodovicz KG; Mehta V; Zhang Q; Zhao C; Davies MJ; Chen J; Radican L; Engel SS
    Curr Med Res Opin; 2013 Feb; 29(2):101-7. PubMed ID: 23198978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hypoglycemia rates and associated costs among type 2 diabetics starting basal insulin therapy in the United States.
    Ganz ML; Wintfeld NS; Li Q; Lee YC; Gatt E; Huang JC
    Curr Med Res Opin; 2014 Oct; 30(10):1991-2000. PubMed ID: 24945720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool.
    Hoskins N; Tikkanen CK; Pedersen-Bjergaard U
    J Med Econ; 2017 Apr; 20(4):363-370. PubMed ID: 27926814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indonesia Cohort of IO HAT Study to Evaluate Diabetes Management, Control, and Complications in Retrospective and Prospective Periods Among Insulin-Treated Patients with Type 1 and Type 2 Diabetes.
    Rudijanto A; Saraswati MR; Yunir E; Kumala P; Puteri HH; Mandang VV
    Acta Med Indones; 2018 Jan; 50(1):26-37. PubMed ID: 29686173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalization.
    Dalal MR; Kazemi MR; Ye F
    Curr Med Res Opin; 2017 Feb; 33(2):209-214. PubMed ID: 27737571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Top 10 Facts to Know About Inpatient Glycemic Control.
    Horton WB; Subauste JS
    Am J Med; 2016 Feb; 129(2):139-42. PubMed ID: 26522798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta-analysis results of four clinical trials.
    Palmer AJ; Roze S; Valentine WJ; Smith I; Wittrup-Jensen KU
    Curr Med Res Opin; 2004 Nov; 20(11):1729-46. PubMed ID: 15537473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.